Effects of chronic administration of doxazosin on α1- adrenoceptors in the rat prostate

Journal of Urology

Volumn 172, Issue 6 I, 2004, Pages 2465-2470

  Foster Jr , Harris E ^a   Yono, Makoto ^a   Shin, David ^a   Takahashi, Wataru ^b   Pouresmail, Mehdi ^a   Afiatpour, Parviz ^c   Latifpour, Jamshid ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KUMAMOTO UNIVERSITY   (Japan)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Doxazosin; Prostate; Prostatic hyperplasia; Receptors, adrenergic

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; DOXAZOSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; LIGAND BINDING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; UPREGULATION;

EID: 8644271695     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000138475.89790.88     Document Type: Article

References (20)

1. Bautista, O. M., Kusek, J. W., Nyberg, L. M., McConnell, J. D., Bain, R. P., Miller, G. et al: Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial. Control Clin Trials, 24: 224, 2003
2. Andersson, K.-E., Chapple C. R. and Hofner, K.: Future drugs for the treatment of benign prostatic hyperplasia. World J Urol, 19: 436, 2002
3. Pool, J. L. and Kirby, R. S.: Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. Int Urol Nephrol, 33: 407, 2001
4. Akduman, B. and Crawford, E. D.: Terazosin, doxazosin, and prazosin: current clinical experience. Urology, suppl., 58: 49, 2001
5. Dunn, C. J., Matheson, A. and Faulds, D. M.: Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging, 19: 135, 2002
6. Djavan, B.: Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life. Urology, suppl., 62: 6, 2003
7. McConnell, J. D., Roehrborn, C. G., Bautista, O. M., Andriole, G. L. Jr., Dixon, C. M., Kusek, J. W. et al: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. New Engl J Med, 349: 2387, 2003
8. Zhang, L., Taniguchi, T., Tanaka, T., Shinozuka, K., Kunitomo, M., Nishiyama, M. et al: Alpha-1 adrenoceptor up-regulation induced by prazosin but not KMD-3213 or reserpine in rats. Br J Pharmacol, 135: 1757, 2002
9. Nishi, K., Wada, Y., Saito, M., Foster, H. E., Jr., Weiss, R. M. and Latifpour, J.: Properties of alpha-1-adrenergic receptors in the rat prostate: effect of experimental diabetes. Urol Int, 61: 147, 1998
10. Yono, M., Takahashi, W., Pouresmail, M., Johnson, D. R., Foster, H. E., Jr., Weiss, R. M. et al: Quantification of endothelins, their receptors and endothelin converting- enzyme mRNAs in rat genitourinary tract using real-time RT-PCR. J Pharmacol Toxicol Methods, 48: 87, 2002
11. Chung, M., Vashi, V., Puente, J., Sweeney, M. and Meredith, P.: Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation. Br J Clin Pharmacol, 48: 678, 1999
12. Kaye, B., Cussans, N. J., Faulkner, J. K., Stopher, D. A. and Reid, J. L.: The metabolism and kinetics of doxazosin in man, mouse, rat and dog. Br J Clin Pharmacol, 21: 198, 1986
13. Bendix Holme, J., Christensen, M. M., Rasmussen, P. C., Jacobsen, F., Nielsen, J., Nørgaard, J. P. et al: 29-Week doxazosin treatment in patients with symptomatic benign prostatic hyperplasia. A double-blind placebo-controlled study. Scand J Urol Nephrol, 28: 77, 1994
14. De La Rosette, J. J. M. C. H., Kortmann, B. B. M., Rossi, C., Sonke, G. S., Floratos, D. L. and Kiemeney, L. A. L. M.: Long-term risk of re-treatment of patients using α-blockers for lower urinary tract symptoms. J Urol, 167: 1734, 2002
15. Milligan, G. and Bond, R. A.: Inverse agonism and the regulation of receptor number. Trends Pharmacol Sci, 18: 468, 1997
16. McCune, D. F., Edelmann, S. E., Olges, J. R., Post, G. R., Waldrop, B. A., Waugh, D. J. et al: Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists. Mol Pharmacol, 57: 659, 2000
17. Vincent, J., Dachman, W., Blaschke, T. F. and Hoffman, B. B.: Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans. J Clin Invest, 90: 1763, 1992
18. Zhong, H. and Minneman, K. P.: Alpha1-adrenoceptor subtypes. Eur J Pharmacol, 375: 261, 1999
19. Koshimizu, T., Tanoue, A., Hirasawa, A., Yamauchi, J. and Tsujimoto, G.: Recent advances in alpha1-adrenoceptor pharmacology. Pharmacol Ther, 98: 235, 2003
20. Kyprianou, N.: Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol, 169: 1520, 2003